Graviti Pharma Pushes India Growth with Karnataka Market Entry

Established in 2012, it operates USFDA-aligned facilities with a capacity of 6 billion tablets, expanding its operations into Karnataka by April 2026.

The Hyderabad-based pharma company, Graviti Pharma, has announced the launch of its operations in Karnataka, strengthening its presence beyond Andhra Pradesh and Telangana while advancing its strategy of building a scalable, quality-focused pharmaceutical platform across key domestic markets.

Graviti Pharmaceuticals is a research-focused pharma company specializing in developing and manufacturing complex, modified-release, and stability-sensitive generic medicines, with a strong presence in the US market.

Established in 2012, it operates USFDA-aligned facilities with a capacity of 6 billion tablets, expanding its operations into Karnataka by April 2026.

India’s pharmaceutical sector is valued at over USD 50 Bn and is a major supplier of generic medicines globally, accounting for nearly 20% of global generic drug exports.

There is an increasing industry focus on complex generics such as modified-release and stability-sensitive formulations, particularly for regulated markets like the United States, where compliance with USFDA standards is mandatory.

Speaking on the occasion, Thilak Vangala, Chief Operating Officer, Graviti Pharmaceuticals, said, “Our entry into Karnataka represents a strategic milestone in our India growth journey. With a strong foundation in international markets and a continued focus on quality and compliance, we are committed to scaling our presence and delivering globally aligned pharmaceutical solutions across key therapy segments.”

Graviti Pharma’s expansion is underpinned by its manufacturing facility at Pashamylaram in Hyderabad, which operates in alignment with USFDA standards. The company has built its foundation through a combination of international exposure and a compliance-driven operating model.

Under the direction of Managing Director Dheeraj Gorukanti and Chief Operating Officer Thilak Vangala, the company has focused on strengthening operational efficiency and expanding its geographic reach in a phased manner.

Stay tuned for more such updates on Digital Health News